Replies to post #190641 on Biotech Values

[north40000]

A few weeks ago, my dermatologist[well regarded in D.C. environs], predicted this approval and said she would use it for her patients, but cautioned the therapy would require many applications.

I still wonder how many people would ask for the treatment. I would not. But appearance conscious Washington, New York, L. A.?

[DewDiligence]

KYTH 1Q15 slide deck features a woman who most definitely does not need Kybella:

http://investors.kythera.com/common/download/download.cfm?companyid=AMDA-MFNLA&fileid=827808&filekey=0e7cb595-83d6-440f-9002-8d67b2e563b4&filename=KYTHERA_2015_First_Quarter_2015_Results_5.7.15.pdf

[DewDiligence]

Dermal fillers such as ACT’s Voluma should be injected only by trained injectors—else serious complications can arise:

http://in.reuters.com/article/2015/05/28/us-fda-dermalfillers-idINKBN0OD2IZ20150528